Cingulate Inc. - Common Stock
Cingulate Inc. - Common Stock
Share · US17248W2044 · CING (XNAS)
Overview Financial Indicators
4,53 USD
4,62 % 0,20 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 20:17

Current Prices from Cingulate Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CING
USD
09.06.2025 20:17
4,53 USD
4,38 USD
+3,42 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
4,62 % 18,23 % 11,03 % 16,75 % 6,59 % -47,77 % -99,58 %

Company Profile for Cingulate Inc. - Common Stock Share

Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.

Company Data

Name Cingulate Inc. - Common Stock
Company Cingulate Inc.
Symbol CING
Website https://www.cingulate.com
Primary Exchange XNAS NASDAQ
ISIN US17248W2044
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Shane J. Schaffer Pharm.D.
Market Capitalization 15 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 1901 West 47th Place, 66205 Kansas City
IPO Date 2021-12-08

Stock Splits

Date Split
09.08.2024 1:12

Ticker Symbols

Name Symbol
NASDAQ CING

More Shares

Investors who Cingulate Inc. - Common Stock hold also have the following shares in their portfolio:
A.MED.SYS.EU 22/28
A.MED.SYS.EU 22/28 Bond
DWS INVEST GLOBAL AGRIBUSINESS LC
DWS INVEST GLOBAL AGRIBUSINESS LC Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025